🇺🇸 FDA
Patent

US 7569588

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61PA61P11/00A61P11/06

Quick answer

US patent 7569588 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P11/00, A61P11/06